Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.

Leonie Maria Frommert,Amanthi Nadira Arumahandi de Silva,Jan Zernicke,Veronika Scholz,Tanja Braun,Lara Maria Jeworowski,Tatjana Schwarz,Pinkus Tober-Lau,Alexander Ten Hagen,Elisa Habermann,Florian Kurth,Leif Erik Sander,Victor Max Corman,Gerd-Rüdiger Burmester,Robert Biesen,Fredrik N Albach,Jens Klotsche

RMD open（2022）

引用 8|浏览9

暂无评分

摘要

Certain immunosuppressive therapies are associated with lower antibody responses after vaccination. Additional factors such as vaccine type, age and vaccination interval should be taken into account. We recommend antibody testing in at-risk patients with AIRD and emphasise the importance of booster vaccinations in these patients.

查看译文

关键词

COVID-19,arthritis, rheumatoid,autoimmune diseases,rituximab,vaccination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要